Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Vertex Pharmaceuticals Inc. (VRTX)

NASDAQ

$549.41

$-8.69

(-1.56%)

Regular Market

Vertex Pharmaceuticals Inc. (VRTX) Live Price Chart

Last updated: ⁦2026-09-04 17:23:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Vertex Pharmaceuticals Inc. (VRTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $549.41, with a market capitalisation of $141.11B and a P/E ratio of 32.10. Over the past 52 weeks, its price has ranged from $374.17 to $560.25. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$141.11B
Open	$557.99
Day's High	$560.25
Day's Low	$7.83
Previous Close	$557.96
Volume	266.42K
Average Volume	--
P/E Ratio	32.10
52-Week High	$560.25
52-Week Low	$374.17
Dividend Yield	--
Earnings Date	--

Vertex Pharmaceuticals Inc. (VRTX) Stock Price Today

Vertex Pharmaceuticals Inc. (VRTX) is currently trading at $549.41 as of 2026-09-04 17:21:00, down 1.53% ($8.56) from the previous close of $557.96

During today's regular trading session, VRTX has traded between $7.83 and $560.25, with a trading volume of 266.42K shares. The current price is near the upper end of today's range.

Vertex Pharmaceuticals Inc. (VRTX) 7-Day Stock Price Change

Over the past seven days, Vertex Pharmaceuticals Inc. (VRTX) moved from $535.38 to $549.41, representing a gain of 2.62% ($14.02).

The stock traded between $549.21 and $557.99 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.

The average daily volume was 924.20 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

VRTX 52-Week Price Position

Position in Range: 94.2%

52W Low$374.17

52W High$560.25

VRTX is currently trading at $549.41, placing it 94.2% of the way from its 52-week low of $374.17 to its 52-week high of $560.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Vertex Pharmaceuticals Inc. (VRTX)?

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Vertex Pharmaceuticals Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	6400
Exchange	NASDAQ
Company Website	https://www.vrtx.com

How to Buy Vertex Pharmaceuticals Inc. (VRTX) Stock on MEXC

Eligible investors can buy real shares of Vertex Pharmaceuticals Inc. (VRTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VRTX and Place Your Order

Open the RealStocks trading page and search for VRTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Vertex Pharmaceuticals Inc. (VRTX) stock price today?

Vertex Pharmaceuticals Inc. (VRTX) is currently trading at $ 549.41, down 1.53% ($8.56) from the previous close of $ 557.96. Intraday prices update in real time during regular trading hours.

2.Is VRTX stock going up or down today?

As of 2026-09-04 17:21:00, VRTX is trading at $ 549.41, down 1.53% ($8.56) from its previous close of $ 557.96. The stock has traded between $ 7.83 and $ 560.25 during today’s regular session. Past price movements do not guarantee future results.

3.What is VRTX pre-market price?

As of 2026-09-04 17:21:00, VRTX is trading at $ 555.48 in pre-market trading, down 0.45% ($2.49) from the previous close of $ 557.96. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VRTX after-hours price?

As of 2026-09-04 17:21:00, VRTX is trading at -- in after-hours trading, -- from the regular-session close of $ 557.96. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VRTX stock trading now?

VRTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VRTX sit relative to its 52-week high and low?

Over the past 52 weeks, VRTX has traded between a low of $ 374.17 and a high of $ 560.25. At $ 549.41, the stock is positioned 94.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Vertex Pharmaceuticals Inc. in?

Vertex Pharmaceuticals Inc. (VRTX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Vertex Pharmaceuticals Inc.'s market capitalisation and where is it listed?

Vertex Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 141.11B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VRTX valued in terms of P/E ratio and EPS?

VRTX trades at a P/E ratio of 32.10, based on trailing-twelve-month EPS of $ 17.38. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Vertex Pharmaceuticals Inc. pay a dividend?

Vertex Pharmaceuticals Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.